Therapie des invasiven Harnblasenkarzinoms
Simone Bier(University of Tübingen), Christian Schwentner(Diakonie-Klinikum Stuttgart), Steffen Rausch(University of Tübingen), J. Böttge(University of Tübingen), Stefan Aufderklamm(University of Tübingen), Ebru Canda(Ege University), Tilman Todenhöfer(University of British Columbia), Georgios Gakis(University Hospital in Halle), Arnulf Stenzl(University of Tübingen), Johannes Mischinger(Medical University of Graz), Omar Halalsheh(University of Tübingen), Derya Balbay(Memorial Sisli Hospital), A. Sim(University of Tübingen)
Cited by 2
Related Papers
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
|European Urology|2020|2.2k
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
|European Urology|2016|1.5k
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|798